The partnership supports the development of medical education events focused on the benefits of ProGen PRP Advantage and SkinPen Precision.
Crown Aesthetics welcomes Jeffrey Rapaport, MD, medical director and founder of Cosmetic Skin and Surgery Center, to partner with its Crown Laboratories’ medical affairs team to help support its customers’ practices with medical education, clinical support, and key opinion leadership development. This partnership will support the development of a suite of medical education events focusing on the significant benefits offered by both ProGen PRP Advantage and SkinPen Precision. These events will also focus on presenting scientifically validated data on Crown Aesthetics devices as well as driving awareness of key factors to consider when purchasing a Platelet Rich Plasma system or microneedling device.
Rapaport has been a practicing dermatologist since 1981 and is certified by the American Board of Dermatology, providing treatment to 4,800 patients per year, and particularly in Aesthetic PRP and hair restoration. “I offer my patients only the highest quality, safest, and best treatment options,” said Rapaport. “Crown’s products, like ProGen PRP and SkinPen, are no exception. The company’s quality and attention to safety far surpass other brand devices on the market and ProGen’s effectiveness at delivering platelets is second to none. This partnership is perfect for my practice and my patients. In fact, I am partnering with Crown Aesthetics to help other physicians interested in PRP achieve the same great results that I am seeing with my ProGen patients.”
“Dr Rapaport is a leader in the field of Aesthetic Dermatology and PRP and we are honored to partner with him to support our partners globally,” said Joe Proctor, president of Crown Aesthetics. “We created a higher safety standard within the microneedling space and have followed suit with PRP by enacting strict protocols with ProGen, including moving all of our PRP manufacturing to the United States. To have one of the top PRP specialists in the country excited to work with ProGen PRP is extremely validating.”
ProGen PRP Advantage is a US FDA 510k cleared Platelet Rich Plasma system indicated for the rapid preparation of autologous Platelet Rich Plasma from a small sample of blood at the patient’s point of care. Made in the USA, ProGen Advantage is designed to be user-friendly with a single spin system that features 15ml and 30ml tubes, yielding 7-15ml of PRP. According to the company, with ProGen Advantage, physicians are now able to deliver Platelet Rich Plasma procedures more efficiently and conveniently. ProGen Advantage is manufactured in an ISO13485 certified manufacturing facility in Irvine, Ca, and sterilized by STERIS Applied Sterilization.
SkinPen Precision is the first-to-market and US FDA-cleared microneedling device clinically proven to improve the appearance of wrinkles of the neck for Fitzpatrick skin types II to IV and to improve the appearance of facial acne scars in adults with all Fitzpatrick skin types aged 22 years and older. SkinPen has passed more than 90 validated tests to set the standard in microneedling. Ergonomically designed based on professional feedback, SkinPen’s ultrasonically sealed handpiece is manufactured to reduce the risk of fluid transfer from the patient to the pen. SkinPen’s superior cartridge was designed to inhibit the entrance of fluids into the device which, along with the BioSheath and routine cleaning, help to prevent potential cross-contamination. The patented cartridge features proprietary technology that includes 14 stainless steel needles that have been validated to stay sharp for a least 80 minutes. With patient safety top-of-mind, the single-use lockout feature eliminates the possibility of double usage and cross-contamination. This safe and versatile treatment can be performed on patients year-round.
